Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “SARS-CoV2 COVID-19”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Ended earlyNCT04341727
What this trial is testing

Hydroxychloroquine,Hydroxychloroquine,Azithromycin in the Treatment of SARS CoV-2 Infection

Who this might be right for
Coronavirus Infection
Washington University School of Medicine 30
Not applicableStudy completedNCT05371561
What this trial is testing

Effect of PPE on Children's Fear in Dental Office

Who this might be right for
COVID-19InfectionsCOVID-19 Virus Infection
Fayoum University 52
Not applicableUnknownNCT04632082
What this trial is testing

Telepsychoeducation for the Prevention of Emotional Distress in Professionals and Students From Essential Services in the Context of COVID-19

Who this might be right for
Mental Health Wellness 1COVIDEmotional Distress+4 more
Hospital de Clinicas de Porto Alegre 2,200
Not applicableStudy completedNCT04376996
What this trial is testing

Slovenian National COVID-19 Prevalence Study

Who this might be right for
COVID-19SARS-CoV-2
University of Ljubljana 3,000
Testing effectiveness (Phase 2)Study completedNCT05954286
What this trial is testing

PROTECT-APT 1: Early Treatment and Post-Exposure Prophylaxis of COVID-19

Who this might be right for
SARS-CoV-2
Henry M. Jackson Foundation for the Advancement of Military Medicine 92
Not applicableUnknownNCT05116657
What this trial is testing

Obstructive Sleep Apnoea Post Covid 19: Role of the Upper Airway Microbiome

Who this might be right for
SleepinessSARS-CoV2 InfectionFatigue Syndrome, Chronic+1 more
Royal College of Surgeons, Ireland 50
Testing effectiveness (Phase 2)Ended earlyNCT04475601
What this trial is testing

Enzalutamide Treatment in COVID-19

Who this might be right for
COVID-19Corona Virus Infection
Andreas Josefsson 42
Testing effectiveness (Phase 2)Study completedNCT05077267
What this trial is testing

ABNCoV2 Vaccine in SARS-CoV-2 (COVID-19) Seronegative and Seropositive Adult Subjects

Who this might be right for
COVID-19 Disease
Bavarian Nordic 197
Testing effectiveness (Phase 2)Study completedNCT05226767
What this trial is testing

Effect of Daily Oral Administration of Food Supplement NLC-V in Patients Diagnosed With COVID-19

Who this might be right for
COVID-19
Todos Medical, Ltd. 31
Not applicableStudy completedNCT05074953
What this trial is testing

Post-COVID-19 Monitoring in Routine Health Insurance Data

Who this might be right for
Virus DiseasesEpidemiology
Technische Universität Dresden 157,134
Testing effectiveness (Phase 2)Study completedNCT04339712
What this trial is testing

Personalised Immunotherapy for SARS-CoV-2 (COVID-19) Associated With Organ Dysfunction

Who this might be right for
COVID-19Virus DiseasesMacrophage Activation Syndrome+1 more
Hellenic Institute for the Study of Sepsis 102
Post-approval studies (Phase 4)UnknownNCT05481177
What this trial is testing

Ivabradine for Long-Term Effects of COVID-19 With POTS Cohort

Who this might be right for
Long Haul COVIDPostural Orthostatic Tachycardia Syndrome
Uniformed Services University of the Health Sciences 250
Not applicableUnknownNCT04381312
What this trial is testing

Direct and Indirect Impact of COVID-19 In Older Populations

Who this might be right for
Risk Factors for COVID-19 Outcomes in Elderly Populations
University Hospital, Grenoble 1,000
Not applicableNo Longer AvailableNCT04337359
What this trial is testing

Ruxolitinib Managed Access Program (MAP) for Patients Diagnosed With Severe/Very Severe COVID-19 Illness

Who this might be right for
Severe/Very Severe COVID-19 Illness
Novartis Pharmaceuticals
Not applicableUnknownNCT06348186
What this trial is testing

Fascial Tissue Response to Manual Therapy: Implications in Long COVID-19

Who this might be right for
COVID-19
University of the State of Santa Catarina 30
Large-scale testing (Phase 3)Study completedNCT07079670
What this trial is testing

Safety and Immunogenicity of NVX-CoV2705

Who this might be right for
COVID-19SARS-CoV-2 Infection
Sanofi 676
Early research (Phase 1)Study completedNCT05220605
What this trial is testing

Nebulised BromAc in Healthy Volunteers

Who this might be right for
COVID-19 PneumoniaBromelains Adverse ReactionAcetylcysteine Adverse Reaction+2 more
Mucpharm Pty Ltd 12
Testing effectiveness (Phase 2)Study completedNCT04635605
What this trial is testing

Methylene Blue Treatment of COVID-19

Who this might be right for
SARS-CoV2
Fondazione Epatocentro Ticino 29
Not applicableStudy completedNCT04481620
What this trial is testing

Development and Validation of a Prediction Model for the Transition From Mild to Moderate Form of COVID-19, Using Data From Chest CT

Who this might be right for
COVID-19
University Hospital, Bordeaux 1,329
Early research (Phase 1)Study completedNCT05148754
What this trial is testing

An Open-label Clinical Study of the Pharmacokinetics and Safety of Elsulfavirine, 200 mg Tablets, With Single and Multiple Oral Administration in Healthy Volunteers

Who this might be right for
Covid19HIV-1-infection
Viriom 15
Next Page